The safety of attenuated and recombinant nasal influenza vaccines in terms of the development of secondary bacterial superinfection
Introduction. Influenza is a severe viral disease. The most common post-influenza complication is pneumonia. Earlier, we developed an experimental mouse model of viralbacterial pneumonia induced by successive infection with influenza virus and St. aureus, in which lethal synergy between pathogens ob...
Main Authors: | N. R. Makhmudova, I. A. Leneva, N. V. Larionova, A. V. Poddubikov, I. N. Falynskova, N. P. Kartashova, O. A. Svitich |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Central Research Institute for Epidemiology
2019-12-01
|
Series: | Журнал микробиологии, эпидемиологии и иммунобиологии |
Subjects: | |
Online Access: | https://microbiol.elpub.ru/jour/article/view/492 |
Similar Items
-
The study of neuraminidase immunity in protection against secondary bacterial pneumonia induced by <i>S. aureus</i> after influenza infection in mice
by: I. A. Leneva, et al.
Published: (2021-01-01) -
INDUCTION OF SECONDARY BACTERIAL PNEUMONIA IN MICE INFECTED WITH PANDEMIC AND LABORATORY STRAINS OF THE H1N1 INFLUENZA VIRUS
by: I. A. Leneva, et al.
Published: (2019-08-01) -
Mutation E48K in PB1 Polymerase Subunit Improves Stability of a Candidate Live Attenuated Influenza B Virus Vaccine
by: Jongsuk Mo, et al.
Published: (2021-07-01) -
Safety, Immunogenicity, and Protective Efficacy of a Chimeric A/B Live Attenuated Influenza Vaccine in a Mouse Model
by: Ekaterina Stepanova, et al.
Published: (2021-01-01) -
Development of a Novel Live Attenuated Influenza A Virus Vaccine Encoding the IgA-Inducing Protein
by: C. Joaquín Cáceres, et al.
Published: (2021-06-01)